Ubenimex enhances Brd4 inhibition by suppressing HEXIM1 autophagic degradation and suppressing the Akt pathway in glioma cells

Inhibition of Brd4 by JQ1 treatment showed potential in the treatment of glioma, however, some cases showed low sensitivity of JQ1. In addition, the pre-clinical analysis showed its limitation by demonstrating that transient treatment with JQ1 leads to aggressive tumor development. Thus, an improved...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Han, Liping, Zhao, Qingwei, Liang, Xianhong, Wang, Xiaoqing, Zhang, Zhen, Ma, Zhiguo, Zhao, Miaoqing, Wang, Aihua, Liu, Shuai
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2017
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5542215/
https://ncbi.nlm.nih.gov/pubmed/28484091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17314
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia